The CD19 Gene Immunodeficiency Common Variable Type 3 Genetic Test is a specialized diagnostic tool designed to identify mutations in the CD19 gene, which are associated with Common Variable Immunodeficiency Type 3 (CVID3). This condition is a primary immunodeficiency disorder characterized by a reduced ability to produce antibodies, leading to an increased susceptibility to infections. The CD19 gene plays a crucial role in the development and function of B cells, which are essential for the adaptive immune response.
Performed at DNA Labs UAE, this test is vital for individuals who exhibit symptoms of immune deficiency, such as recurrent infections, particularly in the respiratory and gastrointestinal tracts. Early and accurate diagnosis through this genetic test can significantly aid in the management and treatment of the condition, improving the quality of life for affected individuals.
The cost of the CD19 Gene Immunodeficiency Common Variable Type 3 Genetic Test is 4400 AED. This investment covers the sophisticated genetic analysis required to detect the presence of mutations in the CD19 gene. Given the complexity and the specialized nature of this test, it represents a critical step towards personalized medicine for patients with symptoms suggestive of CVID3, offering them a pathway to targeted treatments and interventions.
The TNFRSF13C gene plays a crucial role in the immune system, specifically in the functioning of B cells, which are essential for producing antibodies. Mutations in this gene can lead to Immunodeficiency Common Variable Type 4 (CVID4), a type of primary immunodeficiency disorder. This condition is characterized by a marked decrease in the level of immunoglobulins (antibodies) in the blood, leading to an increased susceptibility to infections.
The genetic test for TNFRSF13C gene mutations is a critical tool in diagnosing CVID4. It involves analyzing the DNA to identify any abnormalities in the TNFRSF13C gene that could be responsible for the disorder. This test is crucial for confirming the diagnosis, which can significantly impact the management and treatment plans for affected individuals.
At DNA Labs UAE, the TNFRSF13C Gene Immunodeficiency Common Variable Type 4 Genetic Test is available for individuals who are suspected of having this condition or for those with a family history of immunodeficiency disorders. The test is priced at 4400 AED. Conducting this test in a specialized facility like DNA Labs UAE ensures accuracy and reliability of results, which are critical for making informed medical decisions.
The "CD81 Gene Immunodeficiency Common Variable Type 6 Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the CD81 gene, which are linked to a rare form of immunodeficiency known as Common Variable Immunodeficiency Type 6 (CVID6). This condition is characterized by a significant reduction in the levels of immunoglobulins in the blood, leading to an increased susceptibility to infections. The test is crucial for individuals showing symptoms of immunodeficiency disorders or for those with a family history of such conditions, as it can provide definitive genetic evidence of CVID6.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, this test involves analyzing the patient's DNA to detect abnormalities in the CD81 gene that could impair immune function. The process is meticulous, ensuring high accuracy in results, which are vital for the proper management and treatment of the condition.
The cost of the test is set at 4400 AED, reflecting the comprehensive nature of the genetic analysis and the expertise required to interpret the results. For patients and families affected by immunodeficiency disorders, this test represents a critical step towards understanding their condition and tailoring their treatment to improve their quality of life.
The LRBA gene immunodeficiency common variable type 8 genetic test is a specialized diagnostic procedure designed to identify mutations in the LRBA gene, which are associated with a type of primary immunodeficiency known as common variable immunodeficiency-8 (CVID-8). This condition is characterized by low levels of serum immunoglobulins (antibodies) leading to an increased susceptibility to infections, autoimmune disorders, and potentially an increased risk of malignancy. Patients with mutations in the LRBA gene may exhibit symptoms ranging from recurrent infections to more severe immune system dysfunctions.
The test is conducted at DNA Labs UAE, a facility renowned for its advanced genetic testing capabilities. The procedure involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed using state-of-the-art genetic sequencing technologies to detect mutations in the LRBA gene. This genetic test is crucial for the accurate diagnosis of CVID-8, enabling healthcare providers to tailor treatment strategies to the specific needs of the patient, which may include immunoglobulin replacement therapy, medications to boost the immune system, and other supportive therapies.
The cost of the LRBA gene immunodeficiency common variable type 8 genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to identify the presence of any genetic mutations in the LRBA gene. Early diagnosis and intervention through this genetic test can significantly improve the quality of life for individuals with CVID-8 by reducing the frequency of infections and managing associated symptoms more effectively.
The LAMTOR2 gene plays a crucial role in immune system function by participating in the MAPK signaling pathway, which is essential for cell division, differentiation, and response to external stimuli. A defect in the LAMTOR2 gene, also known as the defect in MAPBP-interacting protein, can lead to immunodeficiency. This condition is characterized by a weakened immune system, making individuals more susceptible to infections and possibly affecting other aspects of health.
To diagnose this specific genetic condition, DNA Labs UAE offers a genetic test targeting the LAMTOR2 gene. The test aims to identify mutations in the LAMTOR2 gene that may result in immunodeficiency due to a defect in the MAPBP-interacting protein. This test is crucial for individuals who have a family history of immunodeficiency or exhibit symptoms related to immune system dysfunction, as it can provide a definitive diagnosis and guide potential treatment options.
The cost of the LAMTOR2 gene immunodeficiency genetic test at DNA Labs UAE is 4400 AED. This investment covers the expenses of the sophisticated genetic analysis required to detect mutations in the LAMTOR2 gene accurately. Once the test is conducted, healthcare providers can use the results to develop a personalized treatment plan, potentially improving the patient's quality of life and managing the symptoms associated with the condition.
The ENPP1 gene hypophosphatemic rickets autosomal recessive type 2 genetic test is a diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the ENPP1 gene, which are known to cause autosomal recessive hypophosphatemic rickets type 2 (ARHR2). This condition is characterized by low levels of phosphate in the blood due to its excessive excretion in the urine, leading to weak and soft bones, a condition known as rickets in children and osteomalacia in adults. The ENPP1 gene plays a crucial role in bone mineralization and regulation of phosphate levels in the body.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for specific genetic mutations in the ENPP1 gene. Identifying these mutations can confirm a diagnosis of ARHR2, which is essential for managing the condition effectively. Early diagnosis can lead to interventions that may include dietary management, phosphate supplements, and vitamin D therapy to improve bone health and prevent complications.
The cost of the ENPP1 gene hypophosphatemic rickets autosomal recessive type 2 genetic test at DNA Labs UAE is 4400 AED. This investment in genetic testing can provide crucial information for affected individuals and their families, guiding treatment plans and helping to predict the course of the disease.
The PHEX Gene Hypophosphatemic Rickets X-Linked Genetic Test is a specialized diagnostic procedure designed to identify mutations in the PHEX gene, which are known to cause X-linked hypophosphatemic rickets (XLH). XLH is a genetic disorder characterized by low levels of phosphate in the blood, leading to weak and soft bones, potentially resulting in bone deformities and other related health issues. This condition is inherited in an X-linked dominant pattern, meaning it can affect both males and females, but males often experience more severe symptoms.
The test is performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities. By analyzing a patient's DNA, the test can confirm the presence of mutations in the PHEX gene, providing crucial information for the diagnosis and management of XLH. Early detection through genetic testing can enable targeted treatment strategies, including phosphate supplements and vitamin D therapy, to manage symptoms and improve quality of life.
The cost of the PHEX Gene Hypophosphatemic Rickets X-Linked Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of obtaining a precise diagnosis to guide effective treatment and management of this condition cannot be understated. For families and individuals at risk of XLH, this test represents a critical step towards understanding and addressing this genetic disorder.
The "DSC3 Gene Hypotrichosis and Recurrent Skin Vesicles Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the DSC3 gene. These mutations are associated with a rare genetic condition characterized by sparse hair (hypotrichosis) and the recurrent appearance of fluid-filled blisters (vesicles) on the skin. The condition is inherited in an autosomal dominant manner, meaning a mutation in just one of the two copies of the gene can lead to the disorder.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the lab for specific genetic alterations in the DSC3 gene. Identifying a mutation in this gene can confirm a diagnosis, helping in the management and treatment of the condition. It can also provide essential information for family planning and genetic counseling for affected families.
The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the DSC3 gene. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, the test offers a crucial resource for individuals and families dealing with the symptoms associated with mutations in the DSC3 gene, facilitating early intervention and personalized care plans.
The APCDD1 gene hypotrichosis type 1 genetic test is a specialized diagnostic tool aimed at identifying mutations in the APCDD1 gene, which are linked to hypotrichosis type 1, a rare genetic condition characterized by reduced hair growth on the scalp and body. This condition is inherited in an autosomal dominant manner, meaning a mutation in just one of the two copies of the gene can lead to the disorder. The test is crucial for confirming a diagnosis, understanding the genetic basis of the condition, and guiding treatment and management decisions.
Performed at DNA Labs UAE, a leading facility in genetic testing and analysis, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab. The laboratory then analyzes the genetic material, focusing on the APCDD1 gene to detect any mutations that are associated with hypotrichosis type 1.
The cost of the APCDD1 gene hypotrichosis type 1 genetic test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test, the expertise required to accurately interpret the results, and the comprehensive service provided by the laboratory, including pre-test counseling, sample collection, genetic analysis, and post-test consultation to discuss the findings.
The SNRPE Gene Hypotrichosis Type 11 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the SNRPE gene that are known to cause Hypotrichosis Type 11. This condition is characterized by a significant reduction in hair density on the scalp and other parts of the body, leading to sparse hair growth from an early age. The test plays a crucial role in confirming the diagnosis, allowing for a better understanding of the condition and facilitating appropriate management and treatment plans for affected individuals.
The testing process involves collecting a DNA sample from the patient, typically through a blood sample or a cheek swab, which is then analyzed in the laboratory to identify any genetic alterations in the SNRPE gene. The accuracy and reliability of the test make it a valuable tool for genetic counselors and healthcare providers in making informed decisions regarding the condition.
The cost of the SNRPE Gene Hypotrichosis Type 11 Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify mutations in the SNRPE gene. For families and individuals facing the challenges of Hypotrichosis Type 11, this genetic test offers hope for a clearer understanding of their condition and the potential for targeted interventions.
